CA2386607A1 - Method for identifying binding partners with position-specific arrays - Google Patents

Method for identifying binding partners with position-specific arrays Download PDF

Info

Publication number: CA2386607A1
Authority: CA; Canada
Prior art keywords: further characterized; array; carrier material; bound; cell lysate
Prior art date: 1999-09-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002386607A

Other languages

English (en)

French (fr)

Inventor

Eberhard Krause

Thomas Bittorf

Jens Schneider-Mergener

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Jerini AG

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-03

Filing date

2000-09-01

Publication date

2001-03-15

2000-09-01 Application filed by Individual filed Critical Individual

2001-03-15 Publication of CA2386607A1 publication Critical patent/CA2386607A1/en

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 70
238000009739 binding Methods 0.000 title claims abstract description 27
230000027455 binding Effects 0.000 title claims abstract description 26
238000003491 array Methods 0.000 title claims abstract description 9
239000012876 carrier material Substances 0.000 claims abstract description 18
239000003446 ligand Substances 0.000 claims abstract description 18
238000004949 mass spectrometry Methods 0.000 claims abstract description 13
239000000203 mixture Substances 0.000 claims abstract description 11
238000006243 chemical reaction Methods 0.000 claims abstract description 5
108090000623 proteins and genes Proteins 0.000 claims description 63
108090000765 processed proteins & peptides Proteins 0.000 claims description 62
102000004169 proteins and genes Human genes 0.000 claims description 59
102000004196 processed proteins & peptides Human genes 0.000 claims description 35
239000013592 cell lysate Substances 0.000 claims description 23
210000004027 cell Anatomy 0.000 claims description 18
150000001413 amino acids Chemical class 0.000 claims description 13
239000012528 membrane Substances 0.000 claims description 12
-1 polypropylene Polymers 0.000 claims description 12
150000001875 compounds Chemical class 0.000 claims description 10
239000006166 lysate Substances 0.000 claims description 10
239000001913 cellulose Substances 0.000 claims description 9
229920002678 cellulose Polymers 0.000 claims description 9
108091005804 Peptidases Proteins 0.000 claims description 7
239000004365 Protease Substances 0.000 claims description 7
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 7
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 6
239000012634 fragment Substances 0.000 claims description 4
108020004707 nucleic acids Proteins 0.000 claims description 4
102000039446 nucleic acids Human genes 0.000 claims description 4
150000007523 nucleic acids Chemical class 0.000 claims description 4
238000012512 characterization method Methods 0.000 claims description 3
238000002330 electrospray ionisation mass spectrometry Methods 0.000 claims description 3
238000001502 gel electrophoresis Methods 0.000 claims description 3
239000000376 reactant Substances 0.000 claims description 3
238000005406 washing Methods 0.000 claims description 3
239000004677 Nylon Substances 0.000 claims description 2
239000004743 Polypropylene Substances 0.000 claims description 2
238000005119 centrifugation Methods 0.000 claims description 2
238000009833 condensation Methods 0.000 claims description 2
230000005494 condensation Effects 0.000 claims description 2
210000003527 eukaryotic cell Anatomy 0.000 claims description 2
238000001914 filtration Methods 0.000 claims description 2
239000000463 material Substances 0.000 claims description 2
229910021645 metal ion Inorganic materials 0.000 claims description 2
229920001778 nylon Polymers 0.000 claims description 2
229920000642 polymer Polymers 0.000 claims description 2
229920005597 polymer membrane Polymers 0.000 claims description 2
229920001155 polypropylene Polymers 0.000 claims description 2
238000001556 precipitation Methods 0.000 claims description 2
210000001236 prokaryotic cell Anatomy 0.000 claims description 2
238000003498 protein array Methods 0.000 claims description 2
239000012508 resin bead Substances 0.000 claims description 2
235000018102 proteins Nutrition 0.000 description 52
238000004458 analytical method Methods 0.000 description 15
230000003993 interaction Effects 0.000 description 14
230000001413 cellular effect Effects 0.000 description 12
108020003175 receptors Proteins 0.000 description 11
102000005962 receptors Human genes 0.000 description 11
101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 10
102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 10
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
235000001014 amino acid Nutrition 0.000 description 9
230000003834 intracellular effect Effects 0.000 description 7
101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 description 6
108010026552 Proteome Proteins 0.000 description 6
102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 6
239000013543 active substance Substances 0.000 description 6
238000013459 approach Methods 0.000 description 6
230000029087 digestion Effects 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
230000002285 radioactive effect Effects 0.000 description 5
101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 4
102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
230000008569 process Effects 0.000 description 4
239000000126 substance Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
238000013519 translation Methods 0.000 description 4
238000010396 two-hybrid screening Methods 0.000 description 4
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 3
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
235000012538 ammonium bicarbonate Nutrition 0.000 description 3
239000001099 ammonium carbonate Substances 0.000 description 3
238000000376 autoradiography Methods 0.000 description 3
239000003814 drug Substances 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
238000011835 investigation Methods 0.000 description 3
230000026731 phosphorylation Effects 0.000 description 3
238000006366 phosphorylation reaction Methods 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
108091093037 Peptide nucleic acid Proteins 0.000 description 2
108010043958 Peptoids Proteins 0.000 description 2
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 2
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 2
102000001253 Protein Kinase Human genes 0.000 description 2
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
239000002220 antihypertensive agent Substances 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
238000005259 measurement Methods 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
108060006633 protein kinase Proteins 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
241000894007 species Species 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
238000001419 two-dimensional polyacrylamide gel electrophoresis Methods 0.000 description 2
235000002374 tyrosine Nutrition 0.000 description 2
QGNCLSQOOODALH-UHFFFAOYSA-N 2-cyano-3-hydroxy-3-phenylprop-2-enoic acid Chemical compound OC(=O)C(C#N)=C(O)C1=CC=CC=C1 QGNCLSQOOODALH-UHFFFAOYSA-N 0.000 description 1
208000010444 Acidosis Diseases 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
101000904177 Clupea pallasii Gonadoliberin-1 Proteins 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
235000016795 Cola Nutrition 0.000 description 1
244000228088 Cola acuminata Species 0.000 description 1
235000011824 Cola pachycarpa Nutrition 0.000 description 1
229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
241000724791 Filamentous phage Species 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
102400000932 Gonadoliberin-1 Human genes 0.000 description 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 1
101500026183 Homo sapiens Gonadoliberin-1 Proteins 0.000 description 1
101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108010024121 Janus Kinases Proteins 0.000 description 1
102000015617 Janus Kinases Human genes 0.000 description 1
229940124091 Keratolytic Drugs 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
102100027633 Protein FAN Human genes 0.000 description 1
101710198122 Protein FAN Proteins 0.000 description 1
102100024550 Sphingomyelin phosphodiesterase 2 Human genes 0.000 description 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
102100040247 Tumor necrosis factor Human genes 0.000 description 1
102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
230000007950 acidosis Effects 0.000 description 1
208000026545 acidosis disease Diseases 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000000556 agonist Substances 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
229940124323 amoebicide Drugs 0.000 description 1
239000002269 analeptic agent Substances 0.000 description 1
230000003555 analeptic effect Effects 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
229940035674 anesthetics Drugs 0.000 description 1
230000000954 anitussive effect Effects 0.000 description 1
229940069428 antacid Drugs 0.000 description 1
239000003159 antacid agent Substances 0.000 description 1
230000003288 anthiarrhythmic effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000002280 anti-androgenic effect Effects 0.000 description 1
230000002082 anti-convulsion Effects 0.000 description 1
230000003474 anti-emetic effect Effects 0.000 description 1
230000001567 anti-fibrinolytic effect Effects 0.000 description 1
230000001857 anti-mycotic effect Effects 0.000 description 1
230000001741 anti-phlogistic effect Effects 0.000 description 1
230000001754 anti-pyretic effect Effects 0.000 description 1
230000003356 anti-rheumatic effect Effects 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
239000000043 antiallergic agent Substances 0.000 description 1
239000000051 antiandrogen Substances 0.000 description 1
229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
239000003416 antiarrhythmic agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
239000000729 antidote Substances 0.000 description 1
229940075522 antidotes Drugs 0.000 description 1
239000002111 antiemetic agent Substances 0.000 description 1
229940125683 antiemetic agent Drugs 0.000 description 1
239000000504 antifibrinolytic agent Substances 0.000 description 1
229940082620 antifibrinolytics Drugs 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
229940030600 antihypertensive agent Drugs 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
239000002543 antimycotic Substances 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000000939 antiparkinson agent Substances 0.000 description 1
229940125688 antiparkinson agent Drugs 0.000 description 1
229940030999 antipsoriatics Drugs 0.000 description 1
239000002221 antipyretic Substances 0.000 description 1
229940125716 antipyretic agent Drugs 0.000 description 1
239000003435 antirheumatic agent Substances 0.000 description 1
229940064004 antiseptic throat preparations Drugs 0.000 description 1
239000003705 antithrombocytic agent Substances 0.000 description 1
239000003434 antitussive agent Substances 0.000 description 1
229940124584 antitussives Drugs 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
230000008901 benefit Effects 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
235000013877 carbamide Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000496 cardiotonic agent Substances 0.000 description 1
230000003177 cardiotonic effect Effects 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
239000000812 cholinergic antagonist Substances 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
229940039231 contrast media Drugs 0.000 description 1
239000002872 contrast media Substances 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
239000003172 expectorant agent Substances 0.000 description 1
230000003419 expectorant effect Effects 0.000 description 1
229940066493 expectorants Drugs 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000003480 fibrinolytic effect Effects 0.000 description 1
229930003935 flavonoid Natural products 0.000 description 1
150000002215 flavonoids Chemical class 0.000 description 1
235000017173 flavonoids Nutrition 0.000 description 1
239000000417 fungicide Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
108020001507 fusion proteins Proteins 0.000 description 1
102000037865 fusion proteins Human genes 0.000 description 1
239000003193 general anesthetic agent Substances 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
229960001442 gonadorelin Drugs 0.000 description 1
239000003630 growth substance Substances 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
150000001469 hydantoins Chemical class 0.000 description 1
239000005555 hypertensive agent Substances 0.000 description 1
239000003326 hypnotic agent Substances 0.000 description 1
230000000147 hypnotic effect Effects 0.000 description 1
239000012133 immunoprecipitate Substances 0.000 description 1
229960001438 immunostimulant agent Drugs 0.000 description 1
239000003022 immunostimulating agent Substances 0.000 description 1
230000003308 immunostimulating effect Effects 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000012482 interaction analysis Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000001155 isoelectric focusing Methods 0.000 description 1
150000002537 isoquinolines Chemical class 0.000 description 1
230000001530 keratinolytic effect Effects 0.000 description 1
239000003410 keratolytic agent Substances 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000008141 laxative Substances 0.000 description 1
229940125722 laxative agent Drugs 0.000 description 1
230000003212 lipotrophic effect Effects 0.000 description 1
239000003912 lipotropic agent Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000003589 local anesthetic agent Substances 0.000 description 1
229960005015 local anesthetics Drugs 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
229940035363 muscle relaxants Drugs 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000002637 mydriatic agent Substances 0.000 description 1
230000002911 mydriatic effect Effects 0.000 description 1
239000003158 myorelaxant agent Substances 0.000 description 1
239000005445 natural material Substances 0.000 description 1
230000002276 neurotropic effect Effects 0.000 description 1
108040005466 neutral sphingomyelin phosphodiesterase activity proteins Proteins 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000002304 perfume Substances 0.000 description 1
238000002823 phage display Methods 0.000 description 1
239000003016 pheromone Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical class O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
210000002307 prostate Anatomy 0.000 description 1
239000011814 protection agent Substances 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
229940001470 psychoactive drug Drugs 0.000 description 1
239000004089 psychotropic agent Substances 0.000 description 1
230000000506 psychotropic effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
229940125723 sedative agent Drugs 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000002048 spasmolytic effect Effects 0.000 description 1
239000000934 spermatocidal agent Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
238000012360 testing method Methods 0.000 description 1
WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
150000003585 thioureas Chemical class 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
239000003204 tranquilizing agent Substances 0.000 description 1
230000002936 tranquilizing effect Effects 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
150000003918 triazines Chemical class 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
230000001549 tubercolostatic effect Effects 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
150000003668 tyrosines Chemical class 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
150000003672 ureas Chemical class 0.000 description 1
239000005526 vasoconstrictor agent Substances 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
239000002544 virustatic Substances 0.000 description 1
230000001790 virustatic effect Effects 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/04—Arrangements for introducing or extracting samples to be analysed, e.g. vacuum locks; Arrangements for external adjustment of electron- or ion-optical components

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Computational Biology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Analytical Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Spectroscopy & Molecular Physics (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Optics & Photonics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

CA002386607A 1999-09-03 2000-09-01 Method for identifying binding partners with position-specific arrays Abandoned CA2386607A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19943743.2		1999-09-03
DE19943743A DE19943743C2 (de)	1999-09-03	1999-09-03	Verfahren zur Identifizierung von Bindungspartnern mit positions-spezifischen Arrays
PCT/DE2000/003071 WO2001018545A2 (de)	1999-09-03	2000-09-01	Verfahren zur identifizierung von bindungspartnern mit positions-spezifischen arrays

Publications (1)

Publication Number	Publication Date
CA2386607A1 true CA2386607A1 (en)	2001-03-15

Family

ID=7921806

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002386607A Abandoned CA2386607A1 (en)	1999-09-03	2000-09-01	Method for identifying binding partners with position-specific arrays

Country Status (9)

Country	Link
EP (1)	EP1212622A2 (cs)
JP (1)	JP2003511652A (cs)
AU (1)	AU7644200A (cs)
CA (1)	CA2386607A1 (cs)
CZ (1)	CZ2002660A3 (cs)
DE (2)	DE19943743C2 (cs)
HU (1)	HUP0203074A2 (cs)
PL (1)	PL353995A1 (cs)
WO (1)	WO2001018545A2 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10141464A1 (de) *	2001-08-23	2004-03-04	Genprofile Ag I.Ins.	Sequenzvarianten des für neuropsychiatrische Krankheiten verantwortlichen Gens 22444 und deren Verwendung
EP1319954A1 (en) *	2001-12-12	2003-06-18	Centre National de Genotypage	Methods for protein analysis using protein capture arrays
US7504364B2 (en)	2002-03-01	2009-03-17	Receptors Llc	Methods of making arrays and artificial receptors
US20030228709A1 (en) *	2002-03-25	2003-12-11	Kozlowski Roland Zbignieiw	Arrays
CN1665790A (zh)	2002-05-03	2005-09-07	莫莱丘莱尔探针公司	用于检测和分离磷酸化分子的组合物及方法
US7445894B2 (en)	2002-05-03	2008-11-04	Molecular Probes, Inc.	Compositions and methods for detection and isolation of phosphorylated molecules
US7469076B2 (en)	2003-09-03	2008-12-23	Receptors Llc	Sensors employing combinatorial artificial receptors
EP1613737A4 (en)	2003-03-28	2008-12-03	Receptors Llc	ARTIFICIAL RECEPTORS COMPRISING REVERSIBLE IMMOBILIZED CONSTRUCTION BLOCKS AND METHODS
US20040248323A1 (en)	2003-06-09	2004-12-09	Protometrix, Inc.	Methods for conducting assays for enzyme activity on protein microarrays
US7884052B2 (en)	2004-09-03	2011-02-08	Receptors Llc	Combinatorial artificial receptors including tether building blocks on scaffolds
EP1789792A2 (en)	2004-09-11	2007-05-30	Receptors LLC	Combinatorial artificial receptors including peptide building blocks

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4027675C2 (de) *	1990-08-31	1997-05-07	Biotechnolog Forschung Gmbh	Verfahren zur parallelen Herstellung von trägergebundenen oder freien Peptiden, trägergebundene Peptide und ihre Verwendung
CA2095633C (en) *	1990-12-03	2003-02-04	Lisa J. Garrard	Enrichment method for variant proteins with altered binding properties
US5834318A (en) *	1995-05-10	1998-11-10	Bayer Corporation	Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
WO1997043301A2 (en) *	1996-05-10	1997-11-20	Novartis Ag	Identification of members of combinatorial libraries by mass spectrometry
US6207370B1 (en) *	1997-09-02	2001-03-27	Sequenom, Inc.	Diagnostics based on mass spectrometric detection of translated target polypeptides
GB9800378D0 (en) *	1998-01-08	1998-03-04	Univ Liverpool	Proteome analysis

1999
- 1999-09-03 DE DE19943743A patent/DE19943743C2/de not_active Expired - Fee Related
2000
- 2000-09-01 DE DE10082703T patent/DE10082703D2/de not_active Expired - Lifetime
- 2000-09-01 CA CA002386607A patent/CA2386607A1/en not_active Abandoned
- 2000-09-01 AU AU76442/00A patent/AU7644200A/en not_active Abandoned
- 2000-09-01 WO PCT/DE2000/003071 patent/WO2001018545A2/de not_active Ceased
- 2000-09-01 EP EP00965834A patent/EP1212622A2/de not_active Withdrawn
- 2000-09-01 CZ CZ2002660A patent/CZ2002660A3/cs unknown
- 2000-09-01 JP JP2001522083A patent/JP2003511652A/ja active Pending
- 2000-09-01 HU HU0203074A patent/HUP0203074A2/hu unknown
- 2000-09-01 PL PL00353995A patent/PL353995A1/xx not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2001018545A2 (de)	2001-03-15
AU7644200A (en)	2001-04-10
DE19943743A1 (de)	2001-03-15
EP1212622A2 (de)	2002-06-12
DE19943743C2 (de)	2002-02-07
WO2001018545A3 (de)	2001-09-13
DE10082703D2 (de)	2002-02-14
CZ2002660A3 (cs)	2002-10-16
JP2003511652A (ja)	2003-03-25
PL353995A1 (en)	2003-12-15
HUP0203074A2 (hu)	2002-12-28

Legal Events

Date	Code	Title	Description
2005-09-01	FZDE	Discontinued

Publication	Publication Date	Title
Annan et al.	2001	A multidimensional electrospray MS-based approach to phosphopeptide mapping
AU2008213716B2 (en)	2012-03-15	Affinity selected signature peptides for protein identification and quantification
James	1997	Protein identification in the post-genome era: the rapid rise of proteomics
Larsen et al.	2000	Mass spectrometric identification of proteins and characterization of their post-translational modifications in proteome analysis
Graves et al.	2002	Molecular biologist's guide to proteomics
Larsen et al.	2001	Phospho‐proteomics: Evaluation of the use of enzymatic de‐phosphorylation and differential mass spectrometric peptide mass mapping for site specific phosphorylation assignment in proteins separated by gel electrophoresis
US6379970B1 (en)	2002-04-30	Analysis of differential protein expression
CA2386607A1 (en)	2001-03-15	Method for identifying binding partners with position-specific arrays
Maguire et al.	2003	Platelet proteomics
Smith et al.	1992	Identification of the posttranslational modifications of bovine lens αB‐crystallins by mass spectrometry
DE1073770T1 (de)	2002-07-04	Neuartiges Verfahren zur Identifizierung von Klonen mit einer gewünschten Biologischen Eigenschaft, ausgehend von einer Expressionsgenbank (2001/06)
US7422865B2 (en)	2008-09-09	Method of identifying peptides in a proteomic sample
WO2003054772A1 (en)	2003-07-03	Methods and devices for proteomics data complexity reduction
Zappacosta et al.	2004	N-terminal isotope tagging strategy for quantitative proteomics: results-driven analysis of protein abundance changes
Goodlett et al.	2002	Proteomics without polyacrylamide: qualitative and quantitative uses of tandem mass spectrometry in proteome analysis
Chen et al.	1996	[12] One bead-one compound combinatorial peptide library: Different types of screening
EP1319954A1 (en)	2003-06-18	Methods for protein analysis using protein capture arrays
US20020192708A1 (en)	2002-12-19	Detection of modified amino acids by mass spectrometry
JP4395439B2 (ja)	2010-01-06	薬物標的の同定のための方法
EP1399741A1 (en)	2004-03-24	Method of mass spectrometry
Chen et al.	2004	Mass spectrometry analysis of synthetically myristoylated peptides
Meyers et al.	2003	Protein identification and profiling with mass spectrometry.
Hauser-Fang et al.	2000	The use of mass spectrometry
Liu	2003	Qualitative analysis of proteomes with isotope labeling
Gronborg et al.	2003	Phosphoprotein and phosphoproteome analysis by mass spectrometry